Inventor · disambiguated record
Yutaka Matsuda
Also filed as: MATSUDA YUTAKA
5 granted patents·14 pending applications·5 citations·filing 2016–2025
68Inventor score
Top patents by PatentIndex Score
19 records- 0186US12024549B2Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereofAJINOMOTO KK·Filed 2019·Granted Jul 2, 2024·3 cites·14 claims
- 0282US11660340B2Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing functionCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted May 30, 2023·2 cites·2 claims
- 0377US12415857B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·21 claims
- 0475US2025302985A1Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereofAJINOMOTO KK·Filed 2025·Application pending·0 cites
- 0575US2025367317A1Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereofAJINOMOTO KK·Filed 2025·Application pending·0 cites
- 0672US2024366783A1Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereofAJINOMOTO KK·Filed 2024·Application pending·0 cites
- 0771US12448451B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Oct 21, 2025·0 cites·20 claims
- 0868US2024285788A1Conjugate of antibody and functional substance or salt thereof, and antibody derivative and compound used in production of the same or salts thereofAJINOMOTO KK·Filed 2024·Application pending·0 cites
- 0968US2024269311A1Regioselective conjugate of antibody and functional substance or salt thereof, and antibody derivative and compound used in production of the same or salts thereofAJINOMOTO KK·Filed 2024·Application pending·0 cites
- 1066US2025101129A1Affinity substance, compound, and antibody and their saltsAJINOMOTO KK·Filed 2024·Application pending·0 cites
- 1165US2024218015A1Methods for producing intermediate antibodies regioselectively modified, and antibody derivatives regioselectively having bioorthogonal functional group or functional substanceAJINOMOTO KK·Filed 2024·Application pending·0 cites
- 1265US2024000965A1Compound or salt thereof, and antibody obtained by using the sameAJINOMOTO KK·Filed 2023·Application pending·0 cites
- 1364US2024115719A1Compound or salt thereof, and antibody obtained by using the sameAJINOMOTO KK·Filed 2023·Application pending·0 cites
- 1464US2024000964A1Compound or salt thereof, and antibody obtained by using the sameAJINOMOTO KK·Filed 2023·Application pending·0 cites
- 1564US2024165260A1Conjugates of antibody and functional substance or salts thereof, and compounds used in production of the same or salts thereofAJINOMOTO KK·Filed 2023·Application pending·0 cites
- 1662US2024058473A1Complex or salt thereof, and method for producing the sameAJINOMOTO KK·Filed 2023·Application pending·0 cites
- 1762US2021139541A1Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereofAJINOMOTO KK·Filed 2020·Application pending·0 cites
- 1858US2024400721A1Uses of dll3-targeting multispecific antigen-binding moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1938US11519901B2Method for screening for cancer therapeutic agentUNIV TOKYO·Filed 2016·Granted Dec 6, 2022·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Yutaka Matsuda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →